← back to search

Xiaozhong Wang

Shantou Central Hospital · CN
🔎 Find collaborators in Pulmonary and Respiratory Medicine · Molecular Biology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Pulmonary and Respiratory Medicine · Molecular Biology
Research interest
Research interests include Ferroptosis and cancer prognosis, RNA modifications and cancer, Cancer-related molecular mechanisms research, and Colorectal Cancer Surgical Treatments.
h-index
21
citations
2,212
works
110
NIH funding
primary concept
email

Recent publications

ZCCHC4 regulates esophageal cancer progression and cisplatin resistance through ROS/c-myc axis
Scientific Reports 2025cited by 8position: lastdoi
Integrated multiomics analysis and machine learning refine neutrophil extracellular trap-related molecular subtypes and prognostic models for acute myeloid leukemia
Frontiers in Immunology 2025cited by 8position: lastdoi
Application of metagenomic next-generation sequencing in pathogen detection of lung infections
Frontiers in Cellular and Infection Microbiology 2025cited by 6position: middledoi
Assessment of prognosis and responsiveness to immunotherapy in colorectal cancer patients based on the level of immune cell infiltration
Frontiers in Immunology 2025cited by 2position: lastdoi
Stable zero-dimensional hybrid indium-based halides with yellow to orange light emission
Dalton Transactions 2025cited by 2position: middledoi
Thermochromic luminescence in low-dimensional antimony halide for detection of trace amount of water and anti-counterfeiting
Chinese Journal of Structural Chemistry 2025cited by 2position: middledoi
Autophagy crosstalk with the immune microenvironment in chronic myeloid leukemia and serves as a biomarker for diagnosis and progression
Frontiers in Immunology 2025cited by 1position: lastdoi
Neoadjuvant Chemotherapy With Oxaliplatin and Fluoropyrimidine Versus Upfront Surgery for Locally Advanced Colon Cancer: The Randomized, Phase III OPTICAL Trial
Journal of Clinical Oncology 2024cited by 56position: middledoi
High-Performance Metabolic Profiling of High-Risk Thyroid Nodules by ZrMOF Hybrids
ACS Nano 2024cited by 21position: middledoi
Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial
PLoS Medicine 2024cited by 17position: middledoi
The therapeutic and biomarker significance of ferroptosis in chronic myeloid leukemia
Frontiers in Immunology 2024cited by 16position: lastdoi
Research progress and the prospect of using single-cell sequencing technology to explore the characteristics of the tumor microenvironment
Genes & Diseases 2024cited by 15position: lastdoi
CD8 + T cell-based molecular subtypes with heterogeneous immune landscapes and clinical significance in acute myeloid leukemia
Inflammation Research 2024cited by 8position: lastdoi
Identification and validation of hub genes and molecular classifications associated with chronic myeloid leukemia
Frontiers in Immunology 2024cited by 7position: lastdoi
The role of ferroptosis-related non-coding RNA in liver fibrosis
Frontiers in Cell and Developmental Biology 2024cited by 7position: middledoi
The role of platelets in the regulation of tumor growth and metastasis: the mechanisms and targeted therapy
MedComm 2023cited by 76position: lastdoi
Engineered Extracellular Vesicles Expressing Siglec‐10 Camouflaged AIE Photosensitizer to Reprogram Macrophages to Active M1 Phenotype and Present Tumor‐Associated Antigens for Photodynamic Immunotherapy
Small 2023cited by 19position: middledoi
Identification of signature of tumor-infiltrating CD8 T lymphocytes in prognosis and immunotherapy of colon cancer by machine learning
Clinical Immunology 2023cited by 12position: lastdoi
Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Initial Results of a Phase III Trial
Annals of Surgery 2022cited by 80position: middledoi
Perioperative chemotherapy with mFOLFOX6 or CAPOX for patients with locally advanced colon cancer (OPTICAL): A multicenter, randomized, phase 3 trial.
Journal of Clinical Oncology 2022cited by 30position: middledoi
Ferroptosis-related molecular patterns reveal immune escape, inflammatory development and lipid metabolism characteristics of the tumor microenvironment in acute myeloid leukemia
Frontiers in Oncology 2022cited by 20position: lastdoi
Identification of inflammatory factor-related genes associated with the prognosis and immune cell infiltration in colorectal cancer patients
Genes & Diseases 2022cited by 5position: lastdoi
Additional file 2 of A novel fatty acid metabolism-related signature identifies features of the tumor microenvironment and predicts clinical outcome in acute myeloid leukemia
Open MIND 2022cited by 0position: lastdoi
Seven Glycolysis-Related Genes Predict the Prognosis of Patients With Pancreatic Cancer
Frontiers in Cell and Developmental Biology 2021cited by 16position: lastdoi
Tumor heterogeneity and clonal cooperation influence the immune selection of IFN-γ-signaling mutant cancer cells
Nature Communications 2020cited by 122position: middledoi
Combining bioinformatics techniques to explore the molecular mechanisms involved in pancreatic cancer metastasis and prognosis
Journal of Cellular and Molecular Medicine 2020cited by 26position: lastdoi
Elevated FPR confers to radiochemoresistance and predicts clinical efficacy and outcome of metastatic colorectal cancer patients
Aging 2019cited by 47position: middledoi
Hemostatic action of lotus leaf charcoal is probably due to transformation of flavonol aglycons from flavonol glycosides in traditional Chinses medicine
Journal of Ethnopharmacology 2019cited by 30position: middledoi
Albumin to fibrinogen ratio and fibrinogen to pre-albumin ratio are economical, simple and promising prognostic factors for solid malignancy
Journal of Thoracic Disease 2019cited by 13position: middledoi
The research progress of LncRNA involved in the regulation of inflammatory diseases
Molecular Immunology 2018cited by 103position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Kaili Liao · Nanchang University8 papers (2018–2025)Fangmin Zhong · Nanchang University8 papers (2022–2025)Bo Huang · Chongqing University7 papers (2013–2024)Fangyi Yao · Nanchang University7 papers (2022–2025)Fan Sun · Nanchang University3 papers (2019–2019)Bo Huang · Nanchang University3 papers (2024–2025)Xue‐Xin Cheng · Nanchang University3 papers (2021–2022)Junyao Jiang · Nanchang University3 papers (2022–2024)Yanmei Xu · Hebei Medical University3 papers (2017–2025)Shuqi Li · The First Affiliated Hospital, Sun Yat-sen University3 papers (2019–2022)Xia-Hong You · Nanchang University3 papers (2018–2019)Hou‐Qun Ying · Guangzhou University of Chinese Medicine3 papers (2017–2019)Qionghui Zhong · Nanchang University3 papers (2018–2025)Qijun Yang · Nanchang University3 papers (2023–2024)Jinting Cheng · Nanchang University2 papers (2023–2025)Haixin Zhao · Chinese PLA General Hospital2 papers (2025–2025)Xiajing Yu · Nanchang University2 papers (2024–2025)Yuhuan Jiang · Nanchang University2 papers (2017–2019)Weiming Yang · Nanchang University2 papers (2018–2019)Jie Liu · The First Affiliated Hospital, Sun Yat-sen University2 papers (2023–2024)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Pulmonary and Respiratory Medicine · Molecular Biology →